Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program
Grundy, S.M.; Cleeman, J.I.; Rifkind, B.M.; Kuller, L.H.
Archives of Internal Medicine 159(15): 1670-1678
1999
ISSN/ISBN: 0003-9926 PMID: 10448768 Document Number: 504665
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
Document emailed within 1 workday
Related Documents
Ernst, N.D.; Cleeman, J.; Mullis, R.; Sooter-Bochenek, J.; Van Horn, L. 1988: The National Cholesterol Education Program: implications for dietetic practitioners from the Adult Treatment Panel recommendations Journal of the American Dietetic Association 88(11): 1401-8 1411Guo, Y.-f.; Hu, D.-y. 2007: Statins in lowering cholesterol in the elderly Zhonghua Nei Ke Za Zhi 46(11): 893-894
2005: Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source MMW Fortschritte der Medizin 147(23): 48-49
Hoppichler, F.; Lechleitner, M.; Patsch, J.R. 1992: Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(11): 523-527
Stoy, N. 1997: Influence of cholesterol on survival after stroke. Beneficial effects of cholesterol lowering on atherosclerosis may not lessen with age Bmj 315(7116): 1158; Author Reply 1159
Moyad, M.A.; Merrick, G.S. 2006: Cholesterol, cholesterol lowering agents/statins, and urologic disease: part i - knowing your numbers Urologic Nursing 26(2): 156-159
Lane, D.M. 2001: Third report of the National Cholesterol Education Program (NCEP. III): A switch from dietary modification to risk factor assessment Current Opinion in Investigational Drugs 2(9): 1235-1236
Appel, S.J.; Floyd, N.A.; Giger, J.Newman.; Weaver, M.T.; Luo, H.; Hannah, T.; Ovalle, F. 2005: African American women, metabolic syndrome, and national cholesterol education program criteria: a pilot study Nursing research 54(5): 339-346
Thiengwiboonwong, S.; Chongsuwat, R.; Temcharoen, P.; Pandii, W.; Pavadhgul, P. 2013: Efficacy of dietary modification following the National Cholesterol Education Program (NCEP) recommendation on lipid profiles among hyperlipidemia subjects Journal of the Medical Association of Thailand 96(10): 1257-1267
Rerksuppaphol, S.; Rerksuppaphol, L. 2015: Metabolic Syndrome in Obese Thai Children: Defined Using Modified 'The National Cholesterol Education Program/Adult Treatment Panel III' Criteria Journal of the Medical Association of Thailand 98 Suppl. 10: S88-S95
Westendorp, R.G.; Smelt, A.H. 1996: Cholesterol synthesis inhibitors: lowering of cholesterol for everybody? Nederlands Tijdschrift Voor Geneeskunde 140(8): 411-414
Simon, K.; Kowalewski, W.; Dobracki, W. 1987: Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver Przeglad Lekarski 44(11): 746-750
Giannini, S.D.; Deveriacki, B.E.; De Góis, J.M.; Diament, J.; Forti, N.; Cardoso, R.H.; Galluci, S.D.; De Serro-Azul, L.G. 1992: Prevalence of primary dyslipidemia in subjects with and without family history of coronary disease, based on the reference values of the "National Cholesterol Education Program" (NCEP) Arquivos Brasileiros de Cardiologia 58(4): 281-287
Henry, D.A.; Cully, L.R.; Grigson, T.; Lee, C. 1991: Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee Medical Journal of Australia 155(5): 332-336
Simoons, M.L.; Casparie, A.F. 1998: Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO Nederlands Tijdschrift Voor Geneeskunde 142(38): 2096-2101
Ali, F.; Laurin, M.-Y.; Larivière, C.; Tremblay, D.; Cloutier, D. 2003: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels Canadian Journal of Clinical Pharmacology 10(3): 101-106
Elcarte López, R.; Villa Elizaga, I.; Sada Goñi, J.; Gascó Eguiluz, M.; Oyarzabal Irigoyen, M.; Sola Mateos, A.; García Ibero, C.; Elcarte López, T.; Ferrer Giménez, M.; Fonteneda Estíbaliz, A. 1993: Study from Navarra. Hyperlipidemia II. Variations according to age and sex in the average cholesterol level, LDL-cholesterol and triglycerides in an infant-child population Anales Espanoles de Pediatria 38(2): 159-166
Grundy, S.M. 1988: Cholesterol education program in the United States Canadian Journal of Cardiology 4 Suppl A: 31a-35a
Ng, T.K. 1993: Blood cholesterol screening: influence of fasting state, biological variation and the single cholesterol assay on total cholesterol level Medical Journal of Malaysia 48(1): 12-16
Schauer, I.; Schauer, U.; Rühling, K.; Thielmann, K. 1980: The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides. Postheparin lipolytic activity and lecithin:cholesterol acyltransferase in hypertensive individuals Artery 8(2): 146-150